Εκπαιδευτικοί πόροι

Εκπαιδευτικοί πόροι

Εξερευνήστε τα εκπαιδευτικά προγράμματα της IMPACT Academy - που προσυπογράφεται από την εξειδικευμένη Συντονιστική Επιτροπή μας

Featured
ΠΡΟΣΦΑΤΑ

Συνιστώμενο περιεχόμενο

COVID-19 and its implications in heart failure
ΠΑΡΟΥΣΙΑΣΗ
COVID-19 and its implications in heart failure
Προβολή Περιεχομένου
Can new-onset diabetes be prevented
ΠΑΡΟΥΣΙΑΣΗ
Can new-onset diabetes be prevented
Προβολή Περιεχομένου
Practicalities of SGLT2 inhibition – pros vs cons
INFOGRAPHIC
Practicalities of SGLT2 inhibition – pros vs cons
Προβολή Περιεχομένου
Updates on ESC heart failure guidelines
VIDEO
Updates on ESC heart failure guidelines
Προβολή Περιεχομένου
Cardiologist Practical Guide to Prescribing
INFOGRAPHIC
Cardiologist Practical Guide to Prescribing
Προβολή Περιεχομένου
Cardiovascular
ΠΡΟΣΦΑΤΑ

Καρδιαγγειακές παθήσεις

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
VIDEO
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Προβολή Περιεχομένου
What did the study tell us about the safety of medicines in heart failure?
INFOGRAPHIC
What did the study tell us about the safety of medicines in heart failure?
Προβολή Περιεχομένου
Hiding in plain sight – how to detect heart failure in primary care
VIDEO
Hiding in plain sight – how to detect heart failure in primary care
Προβολή Περιεχομένου
Optimizing HF discharge care and follow-up
INFOGRAPHIC
Optimizing HF discharge care and follow-up
Προβολή Περιεχομένου
Infection and Vaccines
ΠΡΟΣΦΑΤΑ

Λοιμώξεις και Εμβόλια

Optimizing HF discharge care and follow-up
INFOGRAPHIC
Optimizing HF discharge care and follow-up
Προβολή Περιεχομένου
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
VIDEO
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Προβολή Περιεχομένου
Clinical recommendations for the management of type 2 diabetes
VIDEO
Clinical recommendations for the management of type 2 diabetes
Προβολή Περιεχομένου
Kidney outcomes associated with inhibition of SGLT2
VIDEO
Kidney outcomes associated with inhibition of SGLT2
Προβολή Περιεχομένου
Metabolic
ΠΡΟΣΦΑΤΑ

Μεταβολικά

Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
VIDEO
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Προβολή Περιεχομένου
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
INFOGRAPHIC
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Προβολή Περιεχομένου
Clinical recommendations for the management of type 2 diabetes
VIDEO
Clinical recommendations for the management of type 2 diabetes
Προβολή Περιεχομένου
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
INFOGRAPHIC
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Προβολή Περιεχομένου
Oncology
ΠΡΟΣΦΑΤΑ

Ογκολογία

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
VIDEO
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Προβολή Περιεχομένου
Optimizing HF discharge care and follow-up
INFOGRAPHIC
Optimizing HF discharge care and follow-up
Προβολή Περιεχομένου
Clinical recommendations for the management of type 2 diabetes
VIDEO
Clinical recommendations for the management of type 2 diabetes
Προβολή Περιεχομένου
Medicines in chronic kidney disease
INFOGRAPHIC
Medicines in chronic kidney disease
Προβολή Περιεχομένου
Rare Disease
ΠΡΟΣΦΑΤΑ

Σπάνια νόσος

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
VIDEO
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Προβολή Περιεχομένου
What did the study tell us about the safety of medicines in heart failure?
INFOGRAPHIC
What did the study tell us about the safety of medicines in heart failure?
Προβολή Περιεχομένου
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
INFOGRAPHIC
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Προβολή Περιεχομένου
Chronic kidney disease management
VIDEO
Chronic kidney disease management
Προβολή Περιεχομένου
Renal
ΠΡΟΣΦΑΤΑ

Νεφρικά

Chronic kidney disease management
VIDEO
Chronic kidney disease management
Προβολή Περιεχομένου
Renal protection with SGLT2 inhibitors: what every cardiologist should know
INFOGRAPHIC
Renal protection with SGLT2 inhibitors: what every cardiologist should know
Προβολή Περιεχομένου
Kidney outcomes associated with inhibition of SGLT2
VIDEO
Kidney outcomes associated with inhibition of SGLT2
Προβολή Περιεχομένου
Medicines in chronic kidney disease
INFOGRAPHIC
Medicines in chronic kidney disease
Προβολή Περιεχομένου
Respiratory and Immunology
ΠΡΟΣΦΑΤΑ

Αναπνευστική και Ανοσολογία

The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
INFOGRAPHIC
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Προβολή Περιεχομένου
Clinical recommendations for the management of type 2 diabetes
VIDEO
Clinical recommendations for the management of type 2 diabetes
Προβολή Περιεχομένου
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
INFOGRAPHIC
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Προβολή Περιεχομένου
Chronic kidney disease management
VIDEO
Chronic kidney disease management
Προβολή Περιεχομένου
Προτεινόμενα
ΠΡΟΣΦΑΤΑ

ΠΕΡΙΕΧΟΜΕΝΟ ΕΝΔΙΑΦΕΡΟΝΤΟΣ

The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
ΠΑΡΟΥΣΙΑΣΗ
The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
Προβολή Περιεχομένου
Cardiologist Practical Guide to Prescribing
INFOGRAPHIC
Cardiologist Practical Guide to Prescribing
Προβολή Περιεχομένου
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
VIDEO
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
Προβολή Περιεχομένου
Cardiorenal benefits of SGLT2 inhibitors
ΠΑΡΟΥΣΙΑΣΗ
Cardiorenal benefits of SGLT2 inhibitors
Προβολή Περιεχομένου
Diagnosis and co-morbidities of chronic kidney disease
VIDEO
Diagnosis and co-morbidities of chronic kidney disease
Προβολή Περιεχομένου